Fig. 8From: Roxadustat promotes osteoblast differentiation and prevents estrogen deficiency-induced bone loss by stabilizing HIF-1α and activating the Wnt/β-catenin signaling pathwaySerum levels of bone turnover markers. A Serum levels of BAP in the rats. B Serum levels of OCN in the rats. C Serum levels of TRACP-5b in the rats. Data are presented as the mean ± SD; **P < 0.01, compared with the sham group; #P < 0.05, ##P < 0.01, compared with the OVX groupBack to article page